Valneva wins new U.S. contract for Japanese encephalitis vaccine, Ixiaro

peepo
- French biotech Valneva (NASDAQ:VALN) (OTCPK:INRLF) announced Thursday that the company signed a new one-year contract worth $32.8M with the U.S. Department of Defense to supply its Japanese encephalitis vaccine, branded as Ixiaro.
- The deal, which takes effect immediately, allows the DoD to